Dr. Christos Sotiriou presents a case study for luminal breast cancer, discussing the best therapeutic strategies, the importance of genomic tests, and the potential benefits of chemotherapy for different patient profiles.
00:02 - Clinical Case Description: A 40-year-old woman diagnosed with right breast carcinoma
02:28 - Predictive Tools: Discussion on tools to predict chemotherapy benefits
04:53 - Gene Expression Profiles: The role of gene expression profiles in predicting chemotherapy response
06:15 - Chemotherapy Regimens: Recent data on chemotherapy regimens for high genomic scores
08:30 - Postmenopausal Women: Recommendations for postmenopausal women with luminal cancer
10:45 - Ongoing Studies: Studies addressing chemotherapy versus ovary suppression in premenopausal women